Biotech Values

[genisi]

BMS-650032 will be presented Tue, Nov 03:

"Safety, Tolerability, Pharmacokinetics and Antiviral Activity
following Single- and Multiple-Dose Administration of BMS-
650032, a Novel HCV NS3 Inhibitor, in Subjects with Chronic
Genotype 1 HCV Infection."

ABT has 2 non-nuc polymerase (ABT-333, ABT-072) and Enanta's protease inhibitor (ABT-450).

This SGP's presentation is news:

"High Sustained Virologic Response (SVR) in Genotype 1 (G1) Null Responders to Peg-Interfeon alfa-2b (P) plus Ribavirin (R) When Treated with Boceprevir (Boc) Combination Therapy."